Communist China Has a Death Grip on Critical Medical Supplies, and America Is Unprepared

Communist China has a death grip on our medical supplies and consequently our ability to survive. It is the sole manufacturer of one hundred medications we commonly use, including antibiotics and blood thinners, and is the largest supplier of nitrile gloves, masks, syringes and other medical equipment essential in hospitals.China has threatened to weaponize its monopoly on these supplies to throw our hospitals into chaos, stress us in our death beds, and watch us suffer.When your enemy issues a threat like that, believe it.China’s state-run media publication, Xinhua, warned soon after the outbreak of Covid that China might retaliate against President Trump’s travel ban by banning the export of all medical products, adding that “the United States will fall into the hell of a new coronavirus pneumonia epidemic.”Now, in the trade war with the United States, cutting off medical supplies is possibly China’s next move, and we are not ready.On April 3, only one day after Mr. Trump initially hiked tariffs on Chinese goods, China hit back with a total suspension of exports of rare earth minerals and magnets, its other strategic monopoly besides medical supplies.Rare earth minerals and magnets are essential to manufacture autos, Air Force fighter jets, drones, robots — basically the next generation of warfare materials. China’s move puts a stranglehold on these industries.Unlike the tit-for-tat dance going on between the United States and its friendly trading partners over tariff levels, China’s cutting off exports is an act of raw economic warfare.China is blocking America’s ability to get essential goods at any price. Today, it’s rare earth minerals. Tomorrow, possibly medicines and medical supplies.Global free trade, with zero tariffs, is a goal America can pursue with friendly countries. But not with China, an adversary that aspires to global dominance.India, the other chief supplier to the United States, relies largely on China for basic ingredients, per the Global Trade Research Initiative, an Indian think tank. With almost no other foreign sources for generic medications and medical supplies, the United States has no alternative but to produce these goods at home.The first Trump administration saw that. The former director of the National Economic Council, Gary Cohn, reportedly warned, “If you’re the Chinese and you really want to destroy us, just stop sending us antibiotics.”In 2020, Trump invoked the Defense Production Act, setting a goal of producing a quarter to a third of gloves and other hospital supplies domestically.But the Biden administration floundered in the execution. By 2022, the government had spent roughly $1 billion on half-finished factories to produce nitrile gloves without a single glove to show for it, a sad saga reported by America Affairs. In early 2022, the funding expired, and the Biden administration didn’t bother to request a renewal.Dependence on China for gloves actually increased after 2020, despite the quality being so poor that double gloving is now routine in hospitals to compensate for frequent tearing.Similarly, American imports of finished Chinese pharmaceuticals and active ingredients soared after 2020, per the Atlantic Council, despite Biden paying lip service to reducing dependence.The Strategic Active Pharmaceutical Ingredient Reserve, set up in 2020 to anticipate China cutting off access, was only 1 percent filled as of November 2024, per a report from American Compass trade think tank. That’s shocking negligence.Last week’s clampdown on rare earth minerals is a wakeup call.Congress needs to invest public funds or offer tax incentives to build medical manufacturing capacity. A bill offered last week by Senator Cotton does this.The United States should slap hefty tariffs on China’s medications. Generic drug manufacturers here are more likely to invest in expansion if they know they won’t be blown away by cheap, Chinese competitors.Shift the conversation at Washington, D.C., from shaving drug costs to ensuring access. Domestic manufacturing will cost more, and tariffs will add yet another layer of cost. But the key is to be able to get the drug you need — to prevent a heart attack or dissolve a blood clot — whether China is on the warpath or not.President Xi says “there are no winners in a trade war, or a tariff war.” That’s untrue. America appears poised to win reciprocal tariffs, or no tariffs, with its friendly trading partners. Meanwhile, China has shown its true colors, an adversary trying to bring its trading partners to their knees.America has been warned and must act on it.Creators.com_________Correction: Nitrile gloves are the product of which China is the leading supplier. An earlier version misstated the type of gloves.

Communist China Has a Death Grip on Critical Medical Supplies, and America Is Unprepared

Communist China Has a Death Grip on Critical Medical Supplies, and America Is Unprepared

More from the New York Sun

PGA Tour Unveils Radical Two-Week Match-Play Finale in Landmark Overhaul for 2028

Dolly Parton’s Artistry Transcends Her Legend

DOJ Says Kennedy Center May Be Demolished If Trump’s Name Not Added to the Building

In Major Victory for Trump, Darline Graham Wins South Carolina Republican Primary for Full Term in the Senate

As 11,000 Exemption Bids Pour In, City Delays Pied-à-Terre Deadline Again

Pennsylvania’s Josh Shapiro Backtracks on Data Centers and AI Growth, Threatening Keystone State’s Tech Boom

How Chatbots Are Sending Users Spiraling Into a Delusion Dubbed ‘Sycophantic AI’

Democratic Congresswoman Urges Congressional Leaders To Let Lawmakers Add Pictures Into Legislation

More from the New York Sun

PGA Tour Unveils Radical Two-Week Match-Play Finale in Landmark Overhaul for 2028

Dolly Parton’s Artistry Transcends Her Legend

DOJ Says Kennedy Center May Be Demolished If Trump’s Name Not Added to the Building

In Major Victory for Trump, Darline Graham Wins South Carolina Republican Primary for Full Term in the Senate

As 11,000 Exemption Bids Pour In, City Delays Pied-à-Terre Deadline Again

Pennsylvania’s Josh Shapiro Backtracks on Data Centers and AI Growth, Threatening Keystone State’s Tech Boom

How Chatbots Are Sending Users Spiraling Into a Delusion Dubbed ‘Sycophantic AI’

Democratic Congresswoman Urges Congressional Leaders To Let Lawmakers Add Pictures Into Legislation